Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (2631)	5/20/1998 9:54:00 PM
From: Exacctnt	Read Replies (1) \| Respond to of 9523

Anthony and All, I've been scrolling through messages from the last few days and didn't see any posts regarding the article in Forbes' June 1 issue regarding Pfizer-Monsanto combination. I'm sure most of you heard that DuPont and Monsanto held merger talks and according to the Forbes article, the talks between the two companies broke down. Monsanto, evidently, postponed their acquisitions of DeKalb and Delta and Pineland while discussion took place. Acquiring DeKalb would have brought anti-trust inquiries because DuPont has a stake in Pioneer Seeds. After talks failed, Monsanto proceeded with its offer for the two seed companies. Forbes states that Monsanto could be on the block and up for sale. They claim that Pfizer would be a good potential buyer. "Monsanto's G.D. Searle drug division already is collaborating with Pfizer to promote and distribute the new arthritis drugs." The article continues by saying "the Searle pipeline is chockablock these days, but a company as big as Monsanto is hard pressed to come up with the money necessary to develop and market those drugs to their fullest potential. Pfizer could supply the cash and distribution systems without blinking. A combination with Monsanto would push Pfizer into agricultural products and seeds, a potentially huge market where it is currently unrepresented. Will it happen? Even before Viagra hit the market, Pfizer was on a roll and now nothing seems beyond its reach. What could be more interesting than a chance to use its bankroll -- and research and marketing prowess -- to become as big a player in agriculture as in pharmaceuticals?" What say you - the stockholders of Pfizer? Regards, Bob